We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

HUNTINGTONS DISEASE TREATMENT MARKET ANALYSIS

Huntington’s Disease Treatment Market, By Drug Type (Tetrabenazine, Deutetrabenazine, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022-2028

Published In : Sep 2023
Code : CMI1479
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Valeant Pharmaceuticals International Inc., Alnylam Pharmaceuticals Inc., Ceregene Inc., Lundbeck, Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd., Cortex Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Auspex Pharmaceuticals, SOM Biotech, GlaxoSmithKline, Siena Biotech, Raptor Pharmaceutical, Pfizer limited, Palobiofarma S.L, Omeros and Ipsen are the major players operating in Huntington's disease treatment market.